The Effect of Glucomannan Powder on Improving Gut Microbiota.
Condition(s) studied
Investigational drug(s) / intervention(s)
Glucomannan: 2 packs of glucomannan, 2 grams per pack
Placebo: 2 packs of corn starch, 2 grams per pack
Study summary
The object of this study is evaluating the effects of the Glucommanan on the healthy human subjects who are. In this trial, at most 30 healthy subjects whose ages are 20\~65 years old (15 for placebo and 15 for intervention)will be included. The total experiment will be 9 weeks and the intervention period will be 6 weeks, within which, at week 0, 6, and 7, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), aspartate aminotransferase (AST, also known as GOT), alanine aminotransferase (ALT, also known as GPT), blood urea nitrogen (BUN), serum creatinine (Cr), fasting blood glucose (Glucose, AC) and adiponectin would be measured. Feces samples and anthropometric data will also be acquired. The results will be analyzed according to the methods published by the Ministry of Health and Welfare of Taiwan Food and Drug Administration.
Eligibility
Primary outcome measure(s)
- gut microbiota — Week(0) (Baseline), Wk(6),Wk7
Evaluation of Gut Microbiota by Analysis of Four Indicator Strains and 16S rRNA Sequencing Using Fecal Samples
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Taipei Medical University | Taipei | Taiwan |
More Taipei Medical University trials in Taiwan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07231003 on ClinicalTrials.gov ↗ ← All trials in Taiwan